Publication | Open Access
Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β‐catenin/TCF/LEF signalling
30
Citations
27
References
2019
Year
Our study showed that WISP3 suppressed the progression of HCC by negative regulation of β-catenin/TCF/LEF signalling, providing WISP3 as a potential therapeutic candidate for HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1